NASDAQ:CHRS

Coherus Biosciences Stock News

etoro logo Buy CHRS
*Your capital is at risk
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
AQR Capital Management LLC lifted its stake in shares of Coherus Biosciences Inc (NASDAQ:CHRS) by 145.9% during the 1st quarter, according to the company in its most recent disclosure with the Securit
U.S.-based pharmaceutical giant Amgen wins Appeal Court ruling upholding the patent of its drug Enbrel, Amgen (AMGN) stock is up.
Principal Financial Group Inc. grew its position in Coherus Biosciences Inc (NASDAQ:CHRS) by 1.4% in the first quarter, HoldingsChannel.com reports. The fund owned 47,157 shares of the biotechnology c
REDWOOD CITY, Calif., June 19, 2020 -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective June 18, 2020, the compensation.
Valuing new treatments like remdesivir should reflect cutting-edge assessment methods, reward innovation, and emphasize strategies to improve public health.

2 Top Small-Cap Stocks to Buy Right Now

12:31pm, Friday, 12'th Jun 2020
On June 10, Chair of the Federal Reserve Jerome Powell cautioned that an economic recovery won't be quick or painless. Considering Wall Street had already priced in a relatively optimistic recovery s
State Street Corp raised its holdings in shares of Coherus Biosciences Inc (NASDAQ:CHRS) by 0.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Read more about Lupin, Mylan get European marketing authorisation for biosimilar Etanerce on Devdiscourse
In this article we will check out the progression of hedge fund sentiment towards Coherus Biosciences Inc (NASDAQ:CHRS) and determine whether it is a good investment right now. We at Insider Monkey li
In this article we will check out the progression of hedge fund sentiment towards Coherus Biosciences Inc (NASDAQ:CHRS) and determine whether it is a good investment right now. We at Insider Monkey li
Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
Across Texas a growing number of poor, unemployed or unsuspecting patients are being sued for uncollected medical debt in a trend that some see as predatory.
Across Texas, a growing number of poor, unemployed or unsuspecting patients are being sued for uncollected medical debt in a trend that some see as predatory.
S&P; Dow Jones Indices will make the following changes to the S&P; MidCap 400 and S&P; SmallCap 600 effective prior to the open of trading on Monday, June 1:
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE